
Raily Aesthetic Medicine International Holdings Limited
2135.HKHKSEHealthcareMedical - Care Facilities
Latest quote
HK$0.123
+HK$0.007 · +6.03%
2135.HK company overview
Historical prices · Market data may be delayed.
Company profile
Company websiteRaily Aesthetic Medicine International Holdings Limited is an investment holding company primarily engaged in providing a comprehensive range of cosmetic medical services. Its operations are structured into three principal segments: Aesthetic Medical Services, Consulting Services, and the distribution of Aesthetic Medical Equipment Products. The company's service offerings include various aesthetic procedures such as: Surgical interventions: encompassing cosmetic surgeries performed on different areas of the face or body. Minimally invasive treatments: largely consisting of aesthetic injection procedures. Aesthetic dermatology: featuring diverse energy-based treatments. Aesthetic dental care: including orthodontic services, dental implants, and teeth whitening. Management consulting: providing specialized advisory services for aesthetic medical practices. Furthermore, Raily trades in medical equipment and sells surgical implants alongside aesthetic medical skincare products. The company manages and operates a network of four private, for-profit aesthetic medical clinics located in China's Zhejiang and Anhui Provinces. It serves a diverse clientele, including individual retail customers and other aesthetic medical institutions. Founded in 2008 and headquartered in Hangzhou, People's Republic of China, Raily Aesthetic Medicine International Holdings Limited operates as a subsidiary of Ruide Consultation Limited.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Jianliang Song
- Listed since
- Dec 28, 2020
- Employees
- 264
Market position
Day range
Current HK$0.123
52-week range
Current HK$0.123
- Open
- HK$0.119
- Previous close
- HK$0.116
- Volume
- 10K
- 0.11× average
- Average volume
- 92.45K
- Average daily volume
- Market cap
- 68.52M HKD
- Beta
- 0.39
- Market reference 1
- 50-day average
- HK$0.1069
- +15.06% above average
- 200-day average
- HK$0.1354
- -9.14% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 76.42M CNY
- P/E (TTM)
- 34.01×
- P/B (TTM)
- 0.54×
- P/S (TTM)
- 0.31×
- EV / EBITDA
- 2.83×
- Earnings yield
- 2.43%
- Free cash flow yield
- 42.69%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 40.98%
- Operating margin
- 2.62%
- Net margin
- 0.91%
- Return on equity
- 1.69%
- Return on assets
- 0.77%
- Return on invested capital
- -688.19%
Financial health
- Debt / equity
- 0.55×
- Current ratio
- 0.77×
Earnings
- Latest EPS result
- -0.01
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Mar 19, 2024 | 1:5 | — | — |
Effective Mar 19, 2024
1:5
Continue in GoAI
Research 2135.HKresearch.disclaimer